二尖瓣手术同期房颤消融的应用差异与趋势
基于地区胸外科医师学会数据库2011-2018年7261例二尖瓣手术患者,其中1675例术前房颤者仅64.6%接受同期消融,使用率每年下降2.82%,且与外科医生二尖瓣手术量强相关(高量78.2% vs 中量62.5% vs 低量59.0%,P<.001)。高量医生实施消融的OR为2.2(P<.001),接受消融者出院时房颤比例显著更低(10.1% vs 53.8%,P<.001)。
要点
- 二尖瓣手术同期房颤消融使用率仅64.6%且逐年下降2.82%。
- 高量二尖瓣外科医生实施消融的可能性是低量者的2.2倍。
- 接受消融者出院时房颤比例10.1%,显著低于未消融者53.8%。
核心结论
- 尽管证据和学会推荐增加,二尖瓣手术同期房颤消融仍持续使用不足,存在显著差异。
研究设计与样本
- 回顾性队列研究,查询地区胸外科医师学会数据库2011-2018年7261例二尖瓣手术患者。
主要发现
- 1675例术前房颤患者中1044例(64.6%)接受同期消融。
- 同期消融使用率每年下降2.82%。
- 高量外科医生消融率78.2%,中量62.5%,低量59.0%(P<.001)。
- 高量二尖瓣外科医生实施消融的OR为2.2(P<.001)。
- 消融组出院时房颤比例10.1%,未消融组53.8%(P<.001)。
关键数值与推荐
- STS指南将二尖瓣手术同期房颤消融列为Class IA推荐。
临床怎么用
- 应识别并解决低量中心及低量外科医生同期消融使用不足的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Concomitant surgical ablation for atrial fibrillation (AF) at the time of mitral valve surgery is a Society of Thoracic Surgeons Class IA recommendation with evidence from randomized trial data. We hypothesized that concomitant AF ablation rates have increased over time with implementation of this evidence-based practice. METHODS: All patients (N = 7261) undergoing mitral valve operations (2011-2018) were queried from a regional Society of Thoracic Surgeons database. Patients with preoperative AF were stratified by concomitant AF ablation. Trends in concomitant ablation were evaluated over time as well as by center and surgeon mitral surgical volume. The associations between patient and center factors on implementation of concomitant ablation were assessed with multivariate regression. RESULTS: A total of 1675 patients with preoperative AF underwent isolated mitral valve operations, with 1044 (64.6%) undergoing concomitant ablation. The utilization of concomitant ablation decreased over the study period (-2.82%/year), and was strongly associated with surgeon mitral valve volume (high 78.2% vs medium 62.5% vs low 59.0%; P < .001). Multivariate regression demonstrated age and comorbidities were strong predictors, but high volume mitral surgeons (odds ratio [OR], 2.2; P < .001) were twice as likely to perform concomitant AF ablation. Finally, patients with preoperative AF undergoing ablation were significantly less likely to be in AF at discharge (10.1% vs 53.8%; P < .001). CONCLUSIONS: Despite increasing evidence and societal recommendations, we demonstrate a persistent underutilization of concomitant AF ablation during isolated mitral surgery across a large number of low-volume and high-volume centers. These data suggest significant variability and may represent an opportunity for improvement.
引用
- Mehaffey JH, Krebs E, Hawkins RB, et al. Variability and Utilization of Concomitant Atrial Fibrillation Ablation During Mitral Valve Surgery. Ann Thorac Surg. 2020. PMID: 32693046. doi:10.1016/j.athoracsur.2020.05.125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。